Published in Cancer Genet Cytogenet on April 15, 2005
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22
The clinical approach toward giant cell tumor of bone. Oncologist (2014) 1.46
Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone. Virchows Arch (2009) 1.07
Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour. Virchows Arch (2005) 0.87
p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1. Virchows Arch (2013) 0.81
Giant cell tumor of bone revisited. SICOT J (2017) 0.75
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol (2004) 6.99
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Gene expression analysis of prostate cancers. Mol Carcinog (2002) 2.51
The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol (2005) 1.78
(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Exp Neurol (2010) 1.61
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A (2009) 1.56
Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46
Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med (2004) 1.45
Why good leaders make bad decisions. Harv Bus Rev (2009) 1.40
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. Cancer Invest (2004) 1.33
Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation (2002) 1.23
Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res (2002) 1.22
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin Cancer Res (2002) 1.15
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12
EUS-guided biopsy for the diagnosis and classification of lymphoma. Gastrointest Endosc (2010) 1.09
Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol (2005) 1.08
Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol (2004) 1.05
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials. Blood (2003) 1.00
Molecular evidence for the neoplastic potential of hepatic Von-Meyenburg complexes. Appl Immunohistochem Mol Morphol (2010) 1.00
Interaction of isoflurane with the dopamine transporter. Anesthesiology (2003) 0.99
Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery (2004) 0.99
DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation (2002) 0.99
High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array. Carcinogenesis (2004) 0.96
Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int (2003) 0.95
Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence. Am J Surg Pathol (2004) 0.94
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer (2011) 0.85
Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma (2004) 0.85
Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome. Clin Gastroenterol Hepatol (2006) 0.85
Segmental colitis associated with diverticulosis. Dig Dis Sci (2002) 0.84
Tumor suppressor gene allelic loss profiles of the variants of papillary thyroid carcinoma. Diagn Mol Pathol (2004) 0.84
Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol (2002) 0.84
Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review. Case Rep Med (2010) 0.82
Correlation of the presence and extent of loss of heterozygosity mutations with histological classifications of Barrett's esophagus. BMC Gastroenterol (2012) 0.81
Prospective randomized evaluation of diode-laser and cryotherapy in prethreshold retinopathy of prematurity. Clin Experiment Ophthalmol (2004) 0.80
Assessment of mutational load in biopsy tissue provides additional information about genomic instability to histological classifications of Barrett's esophagus. J Gastrointest Cancer (2014) 0.79
A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol (2003) 0.79
Molecular diagnosis of solid and cystic lesions of the pancreas. Gastroenterol Clin North Am (2004) 0.79
Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification. Curr Oncol Rep (2002) 0.79
Role of farnesyltransferase inhibitors in hematologic malignancies. Expert Rev Anticancer Ther (2004) 0.78
Primary pituitary lymphoma: idiopathic anasarca with relapse in bone marrow only. Acta Haematol (2010) 0.77
Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide (2003) 0.77
Concurrent exposure to heat shock and H7 synergizes to trigger breast cancer cell apoptosis while sparing normal cells. Breast Cancer Res Treat (2003) 0.77
Alemtuzumab until minimal residual disease for chronic lymphocytic leukemia: Is it a new standard? J Clin Oncol (2005) 0.75
First, do no harm; second, make sure you are doing some good. J Clin Oncol (2005) 0.75
Intranasal sufentanil for the treatment of acute pain in a winter resort clinic. Am J Emerg Med (2012) 0.75
Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases. Am J Surg Pathol (2005) 0.75
Phenylephrine and norepinephrine increase dopamine transporter ligand binding in striatum. Mol Imaging Biol (2003) 0.75
Molecular diagnosis of solid and cystic lesions of the pancreas. Clin Lab Med (2005) 0.75
In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter. Nucl Med Biol (2012) 0.75
Thalidomide effects in the post-transplantation setting in patients with multiple myeloma. Hematology (2004) 0.75
Extraskeletal osteosarcoma of subcutaneous soft tissue with lymph node and skin metastasis: a case report with fluorescence in situ hybridization analysis. Pathol Oncol Res (2011) 0.75